{
    "id": "60275296",
    "text": "Liposomal daunorubicin/Cytarabine is a fixed-dose combination of liposomal bound cytarabine and daunorubicin that delivers the two medications in a 5:1 molar ratio. It is used in the treatment of acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC). ==References== Category:Combination drugs ",
    "title": "Daunorubicin/cytarabine"
}